Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction?
Sa'ad T AbdullahiAdeniyi OlagunjuJulius O SoyinkaRahman A BolarinwaOlusola J OlarewajuMoji T Bakare-OdunolaAndrew OwenSaye KhooPublished in: British journal of clinical pharmacology (2019)
This approach highlights additional increase in the already existing risk of suboptimal trough plasma concentration, especially in extensive metabolizers when nevirapine is co-administered with artemether-lumefantrine.
Keyphrases